[
    [
        {
            "time": "2023-10-14",
            "original_text": "数据复盘|近100亿主力资金撤离电子行业 北向资金大幅加仓格力电器",
            "features": {
                "keywords": [
                    "主力资金",
                    "撤离",
                    "电子行业",
                    "北向资金",
                    "加仓",
                    "格力电器"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "电子",
                    "家电"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "数据复盘|近100亿主力资金撤离电子行业 北向资金大幅加仓格力电器",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-14",
            "original_text": "北向资金今日净流出超15亿元，牧原股份遭净卖出9.42亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "净流出",
                    "牧原股份",
                    "净卖出"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "农业"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金今日净流出超15亿元，牧原股份遭净卖出9.42亿元",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-10-14",
            "original_text": "复星医药(02196.HK)拟为控股子公司复星医药产业2.5亿元贷款提供担保 大额借贷担保",
            "features": {
                "keywords": [
                    "复星医药",
                    "贷款",
                    "担保",
                    "子公司"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "复星医药(02196.HK)拟为控股子公司复星医药产业2.5亿元贷款提供担保 大额借贷担保",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-14",
            "original_text": "投资者提问：FDA官网显示，公司的F652用于治疗新冠肺炎的II期临床试验",
            "features": {
                "keywords": [
                    "投资者提问",
                    "FDA",
                    "F652",
                    "新冠",
                    "临床试验"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "投资者提问：FDA官网显示，公司的F652用于治疗新冠肺炎的II期临床试验",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-14",
            "original_text": "市场调整因分化 五板块逆势轮动受青睐！",
            "features": {
                "keywords": [
                    "市场调整",
                    "分化",
                    "板块",
                    "逆势轮动"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "市场调整因分化 五板块逆势轮动受青睐！",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-14",
            "original_text": "港股异动 | 复星医药AH股齐涨 子公司新药获批开展临床试验",
            "features": {
                "keywords": [
                    "港股",
                    "异动",
                    "复星医药",
                    "AH股",
                    "新药",
                    "临床试验"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股异动 | 复星医药AH股齐涨 子公司新药获批开展临床试验",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-14",
            "original_text": "疫苗板块再度拉升，智飞生物、复星医药领涨",
            "features": {
                "keywords": [
                    "疫苗",
                    "板块",
                    "拉升",
                    "智飞生物",
                    "复星医药"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疫苗板块再度拉升，智飞生物、复星医药领涨",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]